Svetlana Nikolaevna Kondratenko (Svetlana N Kondratenko)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Electron Transfer

Positive Breast Cancer

Top Venues

Drug metabolism and personalized therapy

Current drug metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Ekaterina Olegovna Golubenko, Marina Ivanovna Savelyeva, Zhannet Alimovna Sozaeva, Vera Vyacheslavovna Korennaya, Irina Vladimirovna Poddubnaya, Timur Tejmurazovich Valiev, Svetlana Nikolaevna Kondratenko, Mikhail Vitalyevich Ilyin
Predictive modeling of adverse drug reactions to tamoxifen therapy for breast cancer on base of pharmacogenomic testing. Drug metabolism and personalized therapy (2023)
Oksana Dmitryevna Gurieva, Marina Ivanovna Savelyeva, Timur Tejmurazovich Valiev, Zhannet Alimovna Sozaeva, Svetlana Nikolaevna Kondratenko, Mikhail Vitalyevich Ilyin
Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia. Drug metabolism and personalized therapy 38 (4) (2023)
Oksana Dmitryevna Gurieva, Marina Ivanovna Savelyeva, Timur Tejmurazovich Valiev, Zhannet Alimovna Sozaeva, Svetlana Nikolaevna Kondratenko, Mikhail Vitalyevich Ilyin
Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia. Drug metabolism and personalized therapy 38 (4) (2023)
Vladlena I Zozina, Svetlana Nikolaevna Kondratenko, Evgenia V Shikh, Liudmila M Krasnykh, Evgeny S Melnikov, Vladimir G Kukes
The influence of atorvastatin, amlodipine and ethoxidol on ubiquinol and ubiquinone endogenous plasma concentrations in patients with chronic heart failure. Current drug metabolism (2023)
Oksana Dmitryevna Gurieva, Marina Ivanovna Savelyeva, Timur Tejmurazovich Valiev, Zhannet Alimovna Sozaeva, Svetlana Nikolaevna Kondratenko, Mikhail Vitalyevich Ilyin
Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia. Drug metabolism and personalized therapy (2023)